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ABSTRACT 
 
Aims: To assess the estrogenic activity of Manuka honey using the MCF7 cell proliferation assay. 
Study Design:  In vitro cell based E-screen. 
Place and Duration of Study: Ulster University, Coleraine, UK, September 2015 to September 
2016. 
Methodology: Manuka honey (UMF15+) was characterized for total phenolic content (TPC) using 
the Folin-Ciocalteu assay and antioxidant power, using the 2, 2′-azino-bis-3-ethylbenzthiazoline-6-
sulphonic acid (ABTS) assay. Estrogenic activity was assessed using MCF-7 cells cultured in 
DMEM-F2 phenol red-free media supplemented with 10% charcoal stripped FBS and evaluated 
using Sulforhodamine B (SRB) colorimetric assay. All experiments were conducted in triplicate (n-
12-48) and genistein was the positive control. The effect of Manuka honey (UMF15+) treatment on 
intracellular reactive oxygen species (ROS) was measured using the 2'-7'-
dichlorodihydrofluorescein diacetate (DCFH-DA) assay.  
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Results: Manuka honey (UMF15+) antioxidant power was related to total phenols content. MCF7 
growth promotion occurred at very low concentrations of honey (5x10
-6
-5x10
-3
% v/v honey; or 2.75 
x10
-10
M - 2.75 x10
-7
 M TPC) indicative of estrogenic activity whilst higher concentrations of honey 
(>0.5% v/v) were inhibitory. Similarly, the genistein positive control demonstrated estrogenic activity 
indicated by MCF-7 cell growth at low concentrations (5x10
-9
-5x10
-8
 M) and toxicity at high 
concentrations. Estrogenic characteristics were quantified in terms of the relative proliferative 
potency (RPP) and relative proliferative effect (RPE) for Manuka honey of 18% and 22.5-27.5%, 
respectively. For genistein RPP was 0.1% and RPE was 70% compared to values of 100% for 
estradiol. Intracellular ROS increased for MCF-7 cells treated with increasing honey concentrations.  
Conclusion: Manuka honey (UMF15+) exhibits estrogenic activity monitored as growth promotion 
of MCF-7 breast cancer cells with estrogenic parameters being comparable to values reported for 
some purified flavonoids. Treatment of MCF-7 cells produced a dose-dependent rise in intracellular 
ROS. 
 
 
Keywords: Manuka honey; estrogenic activity; breast cancer; antioxidant activity; E-SCREEN, MCF-7. 
 
1. INTRODUCTION 
 
Breast cancer is the major cause of death 
globally amongst women accounting for 25% of 
all cancer and 10% cancer deaths in women [1]. 
Diet is estimated to contribute to nearly 35% of 
all newly diagnosed breast cancers [2]. Alcohol 
consumption and obesity have been correlated to 
breast cancer risk, but attention is also focusing 
on the possible role of environmental estrogens 
[1]. There is increasing interest in the detection of 
plant derived substances which may possess 
estrogenic characteristics [3]. Circulating levels 
of estrogens and dysregulated estrogen signaling 
pathways are implicated in the development and 
progression of some breast cancers and for 
these, treatment is often aimed at the estrogen 
receptor signaling pathway. Tamoxifen, one of 
the most common chemotherapeutic drugs in the 
treatment of estrogen receptor positive breast 
cancer since the 1980s, blocks the estrogenic 
effects on breast cancer cells [4]. Some breast 
cancer patients may show resistance to 
tamoxifen treatment however, increased dosage 
can lead to increasing risks of side-effects on 
normal tissues [5]. A diminished effect of 
chemotherapeutic agents has invited research 
into the role of alternative treatments and 
adjuvants in breast cancer treatment. 
 
Honey has medicinal uses due to its antibacterial 
properties, but is now being considered for its 
antioxidant and anticancer properties. Honeys 
from different floral sources are composed of a 
complex mixture of sugars, protein, minerals, 
vitamins, flavonoids, organic acids, phenolic 
compounds and enzymes; the phytochemicals 
from honey are considered as active bio-
compounds [6-8]. Phenolic compounds are 
amongst the main constituents contributing to 
antioxidant, anticancer, anti-inflammatory and 
other beneficial properties of honey [6-8]. 
Manuka honey has been shown to be high in 
phenolic content [9] with anti-carcinogenic effects 
[10]. We demonstrated recently, that Manuka 
honey inhibition of breast cancer cells was 
related to antioxidant capacity [11]. 
 
Phytoestrogens are plant-derived compounds 
that mimic the female sex hormone 17β-estradiol; 
flavonoids were demonstrated to possess 
estrogenic activity due to the phenolic (ring) 
structure which is similar to the structure of 
endogenous hormones [12-17]. Other 
phytoestrogens, notably genistein in soy, 
exhibited stimulatory activity towards hormone 
sensitive breast cancer cell line MCF-7 [14,18-
21]. There are currently several In-vitro assays 
for environmental estrogens, but the E-SCREEN 
assay which uses MCF-7 (or the MCF-7 Bus) cell 
strains is considered one of the most reliable, 
easy, and rapid to perform [22,23]. The MCF-7 
proliferation assay requires a medium free of 
phenol red as this functions as weak estrogen 
[24]. 
 
Greek thyme honey [25] and Tualang honey [26] 
were reported to show estrogenic activity. With 
the exception of these two publications honey 
estrogenic activity towards MCF-7 cells have not 
been extensively studied. To our knowledge little 
or no research has appeared on the Manuka 
honey estrogenic activity. The overall aims of this 
study are, to address the perceived gap in 
research regarding estrogenic activity in Manuka 
honey. The specific aims of this research were, 
to determine the total phenol content and 
antioxidant effects of medicinal grade Manuka 
honey, to evaluate the estrogenic and cancer 
inhibitory characteristics of Manuka honey 
(UMF15+) using MCF-7 breast cancer cells, and 
to examine the effect of honey treatment on 
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MCF-7 intracellular oxidative stress. The 
hypothesis tested was that Manuka honey 
possesses estrogenic activity which can promote 
MCF-7 cell growth under some circumstances. 
 
2. MATERIALS AND METHODS  
 
2.1 Materials 
 
Manuka honey (UMF15+) was purchased from 
Comvita Ltd (UK). MCF-7 cells were from 
American Type Culture Collection (ATCC). Cells 
were grown in DMEM supplemented with 10% 
FBS, 1% Penicillin, streptomycin mixture and 1% 
non-essential amino acids. For estrogenic 
assays, cells were washed with PBS and 
transferred to DMEM-F2 media lacking phenol 
red (Invitrogen Ltd UK) and supplemented with 
charcoal stripped FBS (Sigma Aldrich). Sodium 
carbonate (≥99.5% purity) and Folin-Denis 
reagent were all purchased from Sigma Aldrich 
Germany. Other laboratory reagents unless 
otherwise stated were from Sigma Aldrich (UK), 
Fisher Scientific UK or GE Healthcare (UK).  
 
2.2 Antioxidant Assays 
 
2.2.1 Instrumentation 
 
Colorimetric measurements were recorded using 
a UV/ Visible spectrophotometer (Ultrospec 2000, 
Pharmacia Biotech, Uppsala Sweden) in 
conjunction with 1-cm polystyrene cuvettes 
(Sarsted Ltd., Leicester, UK). All microplate 
assays involved a 96-microplate reader (VERS 
Amax; Molecular devices, Sunnydale, California, 
USA) with flat-bottomed 96-well microplates 
(NUNC, Sigma Aldrich, UK). Florescence 
measurements for ROS assay were recorded 
using a fluorimeter (FLUOstar Omega, BMG 
Labtech, Germany). 
 
2.2.2 Sample extractions and reference 
antioxidant preparation 
 
Manuka honey (UMF15+) (1g) was diluted in 9 
ml of distilled water and the mixture was 
analyzed for total antioxidant capacity (TAC) and 
total phenolic content (TPC) as described 
below.  
 
2.2.3 The 2, 2-azinobis (3-ethyl-
benzothrazoline-6-sulfonic acid(ABTS) 
radical cation de- colorization assay 
 
The ABTS assay was modified from [27]. Briefly, 
27.4 mg of ABTS and 20 mg of sodium 
persulfate were dissolved with 90 ml and 10 ml of 
phosphate-buffer saline (PBS), respectively. The 
ABTS working solution was prepared in 100 ml 
volumetric flask by mixing ABTS and sodium 
persulfate stock solutions and stored in the dark 
overnight at room temperature. Prior to use, 
ABTS working solution was diluted with PBS until 
an initial absorbance value of 0.85 using a 1cm 
spectrophotometer at 734 nm was obtained. 
Manuka honey test compound was prepared at 
10% or reference compounds (gallic acid, trolox, 
vitamin C) were serially diluted and 20 μl were 
added to separate micro tubes and 1.48 ml of 
ABTS solution was added. The mixtures were 
incubated for 30 min at 37°C. Thereafter 200 μl 
of solutions were distributed to a 96-well plate 
and absorbance measurements were recorded at 
734 nm using a microplate reader. 
 
2.2.4 Total phenolic content- folin assay 
 
2.2.4.1 Analysis of honey total phenols 
 
Total phenolic contents (TPC) were determined 
using the Folin-Ciocalteu method modified from 
[28]. Gallic acid (GA) standard samples (0-1000 
μl) were added to microcentrifuge tubes in 
volumes 1000 μl, 500 μl, 250 μl, 125 μl, 62.5 μl 
and 0.0 μl and topped up to a final volume (1000 
μl) with water. For test analysis of honey, 1g 
honey was diluted with 9 ml distilled water. 
Thereafter, 50 μl of honey test sample was then 
transferred to 6 new microcentrifuge tubes 
followed by 100 μl of Folin-Denis regent and 850 
μl sodium carbonate. The samples were then 
vortexed briefly, incubated at 37°C for 60 min. 
and centrifuged at 11,000 rpm for 5 min. The 
clear supernatant (200 μl) was transferred to a 
96-microplate and absorbance measured at 760 
nm using a microplate reader.  
 
2.3 Cytotoxicity Assay 
 
2.3.1 Cell culture 
 
MCF-7 cells (American Type Cell Culture) were 
grown in DMEM supplemented with 10% FBS,            
1% penicillin, streptomycin mixture and 1% non-
essential amino acids. Culture flasks and 96-
microwell plates were incubated in a humidified 
incubator at 37°C in O2 95% 5% CO2. (LEEC 
research incubator, LEEC, UK). Cells were 
trypsinized, counted using a NucleoCounter (NC-
3000, Chemo Metec, Denmark) and seeded 
(10,000 cells/well) in 96-microwell plates with 50 
μl of phenyl red free culture medium overnight to 
allow cell attachment. Cell growth was monitored 
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using the Sulforhodamine B assay for cell 
cytotoxicity (see below).  
 
2.3.2 Tests for estrogenic activity 
 
Manuka honey was prepared as above (section 
2.2.2) and filter sterilized with 0.20-μm cellulose 
acetate filters. The sterilized solution was then 
diluted with phenyl red-free culture medium 10-
fold to create the following final concentrations  
(5, 0.5, 0.05, 0.005, 0.0005, 0.00005, 0.000005% 
and 0 (control)). Cells were treated with the 
different concentrations and incubated at 37°C 
for 72 hrs (3-days) and 144 hrs (6-days). 
Genistein trials were conducted as positive 
control for estrogenic activity with final 
concentrations (0, 0.005, 0.05, 0.5, 5, and 50 µM) 
and incubated at 37°C for 3 days. From the 
preceding data, we estimated the estrogenic 
potency of honey in terms described by Sato et 
al [21]; relative proliferative potency (RPP) was 
(100 *CH/CE) where CH and CE refer to the lowest 
concentrations of honey and estradiol that 
produce maximum of cell proliferation. The 
relative proliferative effect (RPE) of honey was 
determined from, RPP= 100 *(1-FH) / (1-FE) 
where FH or FE are the observed maximum fold-
increase of cell proliferation after treatment with 
honey or estradiol compared with a non-
treatment control [21]. 
 
2.3.3 In-vitro cytotoxicity tests 
 
Tests were performed as described in section 
2.3.2 with exception that honey concentrations 
were 0, 0.625, 1.25, 2, 2.5, 3.33, 5, 8.5, and 10% 
and incubated at 37°C for 24 hrs and 72 hrs. 
  
2.3.4 Sulforhodamine B (SRB) assay for cell 
numbers 
 
The sulforhodamine B (SRB) assay is a 
colorimetric assay for the quantification of the 
total protein of cells [29]. Cells were treated as 
mentioned above (section 2.3.1). Cells were 
fixed with 100 μl of cold trichloroacetic acid (TCA 
10% v/v), incubated at 5°C for 60 minutes and 
washed with tap water four times. After drying, 
100 μl of SRB dye was added and incubated for 
30 minutes at room temperature. The microplate 
was then washed four times with 100 μl of acetic 
acid (1% v/v). After drying, 200 μl of Trizma base 
solution (10 mM) was added to each microplate 
well to solubilize SRB dye, and the plate was 
shaken using an Orbital Shaker for 5 min (Speed: 
180 revs/min). Absorbance was measured at 564 
nm using a microplate reader. 
  
2.3.5 ROS assay for intracellular antioxidant 
capacity 
 
The ROS assay is a dichlorofluorescein assay for 
the measuring of reactive oxygen species [30,31]. 
Cells were treated as mentioned above (section 
2.3.1). Cells were washed with 200 μl cold Hanks 
balanced salt solution (HBSS) and then removed 
leaving cells suspended in 50 μl HBSS. Cells 
were then treated with 50 μl/well filter-sterilised 
DCHF-DA working solution (49 μl DCFH-DA 
stock solution + 20 ml HBSS) and incubated for 
45 min. (in 5% CO2, 37°C). Cells were then 
washed with 200 μl culture media and treated 
with honey concentrations (10%, 1%, 0.1%, 
0.001%, 0.0001% and 0 (control, media only). 
The plate was then incubated at 37°C for 60 min. 
and read on a fluorimeter at fluorescence 
excitation  485 nm and emission  520 nm.   
 
2.4 Statistical Analysis 
 
All experiments were conducted in three trials 
with 12-48 replicates per drug concentration. 
Routine data analysis was conducted using 
Microsoft Excel. Mean values and standard error 
of mean (S.E.M.) are used in figures. Group 
means were analyzed for statistically significant 
differences using one-way ANOVA followed by 
Tukey’s or Dunnett’s T3 multiple comparisons 
post-hoc test to locate statistically significant 
differences between pairs of means. Where 
variables had unequal variances the Dunnett’s 
T3 post-hoc test was used for the separation of 
means replacing Tukey’s test for non-
homogenous variances. Statistical significance 
was noted with P-values less than 0.05. All 
analyses were performed using IBM SPSS 
Statistics v.22 for Windows, Chicago, IL, USA. 
 
3. RESULTS 
  
3.1 Total Phenols and Antioxidant Power 
of Honey 
 
Fig. 1 shows three ABTS calibrations for 
antioxidant standard references (gallic acid, 
trolox, and vitamin C) used in this study. All 
assays had linear responses with coefficients of 
regression (R2) > 0.98. The data were fitting a 
straight-line equation (Y = x. GRAD) where, Y= 
absorbance and x = concentration of antioxidant, 
and GRAD = slope of the line. 
 
 Fig. 1. ABTS calibration graph for gallic acid, trolox, and vitamin C standards
ABTS= 2,2-azinobis (3-ethyl-benzothrazoline
 
3.2 Evaluation of Manuka Honey 
Estrogenic Activity 
 
Fig. 2 shows the results for Manuka honey 
(UMF15+) estrogenic activity testing, monitored 
from changes in MCF-7 cell proliferation at 3
days (Fig. 2a) or 6-days (Fig.
concentrations of honey in the cell culture media 
were 0-0.5% w/v Fig. 2A (x- axis). M
viability significantly increased at a honey 
concentration 0.000005%. Fig. 2B shows 
changes in MCF-7 cell viability following 6
treatment increased significantly at honey 
concentrations of 0.000005, 0.00005, 0.0005 and 
0.005% (corresponding to a TPC of 2.75 x10
2.75x 10-9 M, 2.75 x10-8 M, 2.75 x10
respectively.  Taking the minimum dose of honey 
that produces maximum cell stimulation as 
0.0005% w/v (a conservative estimate) the total 
phenols content was 2.75x 10
-9
 M (see above), 
and RPP was calculated as ~18%, compared to 
a minimal dose 5x10
-10
 M for estradiol (E2) [21]. 
The maximum fold-increase in MCF
numbers was 1.45-1.55 after treatment with 
honey (Fig. 2) compared to non-treated controls 
and consequently, RPE was 22.5
honey, using a literature maximum
of 3.0 for beta-estradiol [22,23]. 
 
3.3 Genistein Estrogenic Activity
 
Fig. 3 shows genistein positive control for 
estrogenic testing using MCF-7 cells for 3
(72 hrs). The concentrations of genistein in the 
cell culture media were 0-50 x10
-6
 
showed that MCF-7 cell proliferation increased 
by a maximum of 238% at concentrations 
between 1x10-8 M, and 5x 10-7 M compared with 
cells treated with media only. Therefore,
for RPP and RPE for genistein were estimated 
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-6-sulfonic acid radical cation de-colorization assay
(UMF15+) 
-
 2b). The 
CF-7 cell 
-day 
-10
 M, 
-7 M GAE, 
-7 cells 
-27.5% for 
-fold increase 
 
-days 
M. The tests 
 values 
as 0.1% and 90% in good agreement with values 
reported previously [21].  
 
 
Fig. 2a. Estrogenic activity of Manuka honey 
(UMF15+) evaluated with MCF
Cell viability was determined after 3
sulforhodamine B (SRB) assay. Values are means and 
their standard errors represented by vertical bars. 
Mean values with unlike letters were si
different (p <0.05) 
 
 
Fig. 2b. Estrogenic activity of Manuka honey 
(UMF15+) evaluated with MCF
Cell viability was determined after 6
sulforhodamine B (SRB) assay. Values are means and 
their standard errors represented by vertical bars. 
Mean values with unlike letters were si
different (p <0.05) 
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-7 cells 
-days by 
A. B 
gnificantly 
 
-7 cells 
-days by 
A. B 
gnificantly 
Table 1. Total phenols content and antioxidant power for Manuka honey (UMF +15)
 
Assay/ reference Gallic acid
   TPC (mg/100 g) 96.7 ± 3.2
TPC (mol/L)* 7.95 x 10
AOP (mg/100 g) 2045.54
AOP (mol/L)* 168 x10
♣ Total Phenols Content (TPC) by Folin
value not determined. * =values as equivalent 
(gallic acid), 250.16 g/mol (trolox) or 176.12 g/ mol (vitamin C), e.g. TPC (mol/l) = TP (mg/100g honey) x 10 x 
 
 
Fig. 3. Genistein estrogenic activity testing using MCF
Values are means and their standard errors (n=12). Mean values with unlike letters were s
 
3.4 Cell Cytotoxicity Changes Due 
Honey 
 
Cytotoxicity tests for Manuka honey 
(UMF15+) were performed using treatment 
durations of 1-day (Fig. 4, right panel) or 3
(Fig. 4 right panel) to match conditions 
used previously in our laboratory [11]. The 
concentrations of honey in the cell culture media 
  
 
Fig. 4. Effect Manuka honey (UMF15+) on MCF
24 hrs (Left panel) and 72hrs (Right panel) exposure by sulforhodamine B (SRB) assay. 
Values are means and standard errors (n=18).
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 Trolox Vitamin C
 ND ND
-3 ND ND
 12118.59 10121.78
-3 679 x10-3 804.0 x10
-Ciocalteu assay; Antioxidant Power (AOP) by ABTS assay. (mol/L). ND= 
concentrations (mol/l of honey) calculated with FW = 170.2 g/ mol 
density of honey (1.4 kg/L)/ FW 
-7 cell viability as index
ignificantly different 
(p<0.05) 
to 
                
-days 
                 
were 0-10% w/v or 0-8% honey (Fig
With 24 hr treatment (Fig. 4 left panel) MCF
cell viability significantly declined at honey 
concentration 3.33% (184 x 10-6 M GAE). Fig
(Right panel) shows changes in MCF
viability following 3-day treatment with Manuka 
honey (UMF15+). MCF-7 cell viability 
significantly declined at honey concentration >
2.5% (~140 x10-6 M GAE). 
 
-7 cell viability 
 
Mean values with unlike letters were significantly different (P < 
0.05) 
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-3 
 
 
. 4; x- axis). 
-7 
. 4 
-7 cell 
   
 
 
3.5 Intracellular Reactive Oxygen Species 
Assay  
 
The intracellular ROS for cells treated with 
different honey concentrations were measured 
using the cell-permeable and ROS sensitive dye, 
2′,7′-dichlorofluorescin diacetate (DCFH
DCFH-DA, originally non-fluorescent compound, 
is de-acetylated by intracellular esterase, and 
then oxidized to highly fluorescent 2
dichlorofluorescein (DCF) by intracellular ROS 
[30,31]. There was a significant increase in 
fluorescence intensity at all honey concentrations 
compared to non-treated cells control (Fig. 5).
 
4. DISCUSSION 
 
4.1 Total Phenols Content and 
Antioxidant Power  
 
Several assays have been proposed for the 
measurement of the antioxidant capacity of 
honey however the general recommendation is 
to use more than one, therefore ABTS (gallic 
acid, trolox and vitamin C) and Folin
were chosen for this study [32,33,34]. Prior et al 
[35] noted variations in antioxidant assay 
methods and suggested a requirement for more 
than one method for analysis.   
 
The total phenolic content (TPC) is considered 
an indicator of antioxidant capacity [32,33]. In 
   
 
Fig. 5. Effect Manuka honey (UMF15+) on MCF07 cell intracellular reactive oxygen species
Y-axis shows ROS measured from % change in DEFHC fluorescence compared with media
are means and their standard errors represented by vertical bars. 
 
Table 2. Total phenols content for select Manuka honeys from the literature and this study
 
Honey 
Manuka honey 
Manuka honey 
Manuka honey 
Manuka honey  
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-DA). 
′,7′-
 
-Ciocalteu 
this study, Manuka honey (UMF15+) exhibited a 
TPC of 96.7±3.2 mgGAE/100 
comparable to values reported from other 
Manuka honeys (see Table 2). Portokalakis et al. 
found the same 15+ Manuka honey TPC to be 
204.2 mg GAE/100 g [11]. The lower TPC value 
for honey from this study was suggested to be 
due to the older age of the product. A high 
correlation between TPC and antioxidant 
capacity has been reported in studies of other 
honeys [32] and also confirmed by Portokalakis 
et al. [11]. However, it was found that the 
antioxidant capacity UMF 15+ and 18+ Manuka 
honey were not significantly different, though the 
TPC was significantly greater in UMF18+ 
Manuka honey [11]. From such observations, it 
was inferred that polyphenols are not the only 
bioactive compounds influencing an
capacity in Manuka honey as measured by 
chemical methods. Components including, 
glucose oxidase, catalase, organic acids, and 
amino acids may contribute to antioxidant power 
[7,33]. 
 
4.2 Estrogenic Characteristics of Manuka 
Honey Compared to Genistein
 
Estrogenic effects of have been noted for a 
diverse range environmental and dietary 
compounds [22,23]. Their widely different 
chemical structures make it difficult to measure 
estrogenic compounds using simple chemical
-treated cells. Values 
A. B, AB, C 
Mean values with unlike letters were 
significantly different (P <0.05) 
TPC (mgGAE/100 g) Reference
37.2-57.6 [36] 
136.7-235.8 [11] 
90.3-270.6  [9] 
96.7  This study
 
 
 
 
.29887 
 
 
g which is 
tioxidant 
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analysis. Animal testing is also undesirable and 
expensive. The E-SCREEN assay used in this 
study measures MCF-7 cell growth and is 
recognized as valid for large-scale screening, 
reliable, easy, and quick to perform [22,23,37].  
 
The identity of estrogenic compounds in Manuka 
honey was not investigated in this initial study. 
However, candidate estrogenic components from 
honey are likely to be flavonoids.  Past research 
showed that flavonoids mediate estrogenic 
activity [12-17]. Manuka honey was reported to 
have a total flavonoids content of 27.7-33.4 
mg/Kg consisting mainly of quercetin (13%), 
isorhamnetin (12.9%), chrysin (12.6%) and 
luteolin (12.6%); see [38]. The total flavonoid 
content for UMF5+ Manuka honey was 34.5 mg 
catechin equivalents/ kg corresponding to ~1.6 x 
10
-4
M [39]. After 10
4
-fold dilutions employed in 
this study, then flavonoid concentrations would 
reach approximately 1x 10
-8
M which agrees with 
the concentrations of flavonoids shown to 
produce estrogenic responses [12-17]. 
 
Genistein utilized as positive control in the 
current study is well documented for its 
estrogenic activity [14,18-21,40]. Lippman et al. 
[41] were first to observe a biphasic effect of 
estrogen on MCF-7 growth with stimulation 
maximum at 10
-7
M concentration and growth 
inhibition at 10
-6 
M or higher concentrations. 
Quercetin and genistein also displayed a 
biphasic effect on MCF-7 cells as potent 
estrogen agonists at low concentrations (1x10-8 
M) and with growth inhibition at high (2x10
-5 
M) 
concentrations [13,16,42]. The genistein results 
from this study show this biphasic effect with 
MCF-7 cell stimulation at concentrations 5x10
-9
M, 
5x10-8 M, 5x10-7 M and cytotoxicity at higher 
concentrations 5-50x10
-6 
M. The stimulation and 
inhibitory effects seen with MCF7 cells may 
involve different pathways [14,18-21,40].  
 
A comparison of the estrogenic parameters for 
honey (RPP= 18% and RPE= 22.5-27.5%) and 
genistein (RPP= 0.1%, RPE= 90%) is informative. 
First, Manuka honey produced MCF-7 growth 
stimulation at a relative dose of 0.18 compared to 
0.01 for genistein (on a scale with estradiol= 1.0). 
The estimates for genistein agree with previous 
reports which indicate that this agent binds to the 
estrogen receptor with an affinity 20-100x lower 
than 17β-estradiol [14,18-21,40]. The values for 
RPE suggest that honey produced a maximum 
cell stimulation amounting to 22.5-27.5% of the 
value observed with estradiol compared to 
genistein RPE of 70-90% as compared estradiol. 
The differences in RPP relates to dose/ affinity of 
different agents for estrogen receptors. However, 
values of RPE relate MCF-7 cell maximal growth 
stimulation (regardless of the maximum dose 
applied) and is likely affected by the proportion of 
receptor sites occupied when cells are exposed 
to excess agent [22,42]. The reason for the 
comparatively low RPE value for honey is not 
certain at present. 
 
4.3 Cell Viability 
 
Cancer mortality rates remain high despite 
modern scientific breakthroughs and discoveries. 
Interest in alternative treatments for breast 
cancer have increased recently, owing 
undesirable side effects from chemotherapy, 
radiotherapy and surgery, as well as decreased 
sensitivity to commonly used chemotherapeutic 
drugs such as tamoxifen [10]. The cytotoxic 
effects observed for Manuka honey, are in good 
agreement with reports by Fernandez-Cabezudo 
et al. and Portokalakis et al. showed that treating 
MCF-7 cells with Manuka honey (UMF5+ - 
UMF18+) produced dose-dependent declines in 
cell viability [10,11]. 
  
4.4 ROS Assay 
 
Reactive oxygen species (ROS) can disrupt                
the balance of the intra and extracellular 
environment of a cell, resulting in carcinogenic 
effects that can lead to cancer. The free radical 
scavenging activity of honey has been linked the 
phenols in Manuka honey to antioxidant activity 
expressed by scavenging ROS and superoxide 
anions [32]. In this study, we found that treatment 
of MCF-7 cells with honey produced significant 
increases in ROS. Thus, it was hypothesized, 
that total intracellular ROS rise for MCF-7 cells is 
related to TPC (Fig. 5). 
 
5. CONCLUSION 
 
The TPC of honey (Folin assay results) was 
related to antioxidant capacity, determined by the 
ABTS method, which is in agreement with other 
studies. Manuka honey showed estrogenic 
activity monitored using MCF-7 breast cancer 
cell growth promotion assay. The bi-phasic MCF-
7 cell response was seen, and high 
concentrations of Manuka honey inhibited cell 
growth, consistent with previous research of 
estrogens and phytoestrogens [13,16,41,43]. 
Changes in intracellular ROS increased in a 
concentration-dependent manner, suggesting 
ROS formation is related to TPC for honeys. This 
is surprising in view of past studies linking 
honeys phenols with ROS scavenging [44]. 
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The main limitations of this study is due to its In 
vitro design which means the results should not 
be extrapolated to human or animal models. 
However, the value of MCF-7 In vitro screening 
for dietary and environmental estrogenic agents 
is well recognized. Interestingly, the 
concentrations of honey (and associated nominal 
TPC or flavonoid) concentration demonstrated to 
stimulate MCF-7 growth are within achievable 
physiological concentrations observed in humans 
[45]. By contrast, the concentrations required to 
exhibit cytotoxicity towards MCF-7 cells have yet 
to be achieved in human models. Further 
research is needed to understand better the 
effect of Manuka honey on breast cancer cells.  
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